0001541157 EX-FILING FEES Other 0001541157 2025-07-29 2025-07-29 0001541157 1 2025-07-29 2025-07-29 0001541157 2 2025-07-29 2025-07-29 0001541157 3 2025-07-29 2025-07-29 0001541157 4 2025-07-29 2025-07-29 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

Exhibit 107

 

Calculation of Filing Fee Tables

Form S-3
(Form Type)

Akari Therapeutics, PLC
(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities and Carry Forward Securities

 

   Security Type  Security
Class
Title
  Fee
Calculation
Carry
Forward
Rule
   Amount
Registered
   Proposed
Maximum
Offering
Price Per
Unit
   Maximum
Aggregate
Offering Price
   Fee Rate   Amount of
Registration
Fee
   Carry
Forward
Form Type
   Carry
Forward
File Number
   Carry
Forward
Initial
effective
date
   Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
be Carried
Forward
 
Newly Registered Securities  
Fees to Be Paid  Equity  Ordinary shares, par value $0.0001 per share (1)   457(o)                                                      
Fees to Be Paid  Other  Warrants   457(o)                                       
Fees to Be Paid  Other  Units (2)   457(o)                                       
Fees to Be Paid  Unallocated
(Universal) Shelf
  Unallocated (Universal) Shelf (3)   457(o)          $75,000,000   $0.0001531   $11,482.50                    
Fees Previously Paid                                               
Carry Forward Securities  
Carry Forward Securities                                                       
   Total Offering Amounts             $75,000,000        $11,482.50                    
   Total Fees Previously Paid                                            
   Total Fee Offsets                                            
   Net Fee Due                       $11,482.50                    

 

(1) The ordinary shares registered hereby will be represented by the registrant’s American Depositary Shares (“ADSs”), each of which will represent two thousand (2,000) ordinary shares of the registrant. Such ADSs issuable on deposit of the ordinary shares registered hereby have been registered under three separate registration statements on Form F-6 (File Nos.: 333-185197, File No. 333-234213 and File No: 333-262049).
   
(2) Each unit will represent an interest in two or more other securities, which may or may not be separable from one another.
   
(3) There are being registered hereunder such indeterminate number of ordinary shares; such indeterminate number of warrants to purchase ordinary shares and such indeterminate number of units consisting of any combination of ordinary shares and/or warrants as may be sold by the registrant as shall have an aggregate initial offering price not to exceed $75,000,000. Any securities registered hereunder may be sold separately or in combination with other securities registered hereunder. The proposed maximum offering price of the securities will be determined, from time to time, by the registrant in connection with the issuance by the registrant of the securities registered hereunder. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended, (the “Securities Act”), the ordinary shares being registered hereunder include such indeterminate number of ordinary shares as may be issuable as a result of share splits, share dividends or similar transactions. The proposed maximum aggregate offering price reflected in the table has been estimated solely for purposes of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).